ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Regular · Growth
NAV
₹44.1500
as of 17 Nov 2026
Expense Ratio
1.86%
AUM
₹6,830 Cr
Lumpsum returns (CAGR)
- 1Y
- +8.18%
- 3Y
- +20.39%
- 5Y
- +17.15%
- Since Inception
- +19.47%
SIP returns (XIRR)
- 1Y
- +16.44%
- 3Y
- +13.75%
- 5Y
- +19.27%
- Since Inception
- +20.36%
What history actually did — last 8 years (Nov 2018 – Nov 2026)
A ₹5,000 monthly SIP for the last 8 years (Nov 2018 – Nov 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹11,01,667 today — ₹4,80,000 invested, 20.4% XIRR.
₹4,80,000
Invested
₹11,01,667
Value today
20.4%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 8 years (Nov 2018 – Nov 2026)
Real NAV backtest
₹1,00,000 invested 8 years ago would be ₹4,40,060 today (20.3% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Nov 2018 would still hold ₹32,98,930.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹11,01,667 in this fund vs ₹8,38,834 in the benchmark — outperformance of ₹2,62,833.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 8 years (Nov 2018 – Nov 2026) (22 Mar 2020) would be ₹5,00,792 today (5.01×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.32
Sharpe Ratio
+0.05
Alpha
0.68
Beta
0.32
Sortino
13.02%
Std Dev
-12.27%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 30 Jun 2026- Pharmaceuticals & Biotechnology75.78%
- Healthcare Services11.50%
- Retailing5.35%
- Insurance1.33%
- Chemicals & Petrochemicals1.33%
- Healthcare Equipment & Supplies0.77%
Each sector links to the mutual funds most exposed to it.
Thinking about ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Portfolio holdings
- 1Sun Pharmaceutical Industries Ltd.12.69%
- 2Dr. Reddy'S Laboratories Ltd.8.45%
- 3Cipla Ltd.6.56%
- 4Divi'S Laboratories Ltd.6.03%
- 5Mankind Pharma Ltd.5.47%
- 6Alkem Laboratories Ltd.5.11%
- 7Biocon Ltd.4.97%
- 8Cohance Lifesciences Ltd.3.92%
- 9Medplus Health Services Ltd3.80%
- 10Syngene International Ltd.3.26%
What this fund does
ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by ICICI Prudential Mutual Fund. The fund has been operational for over 8 years. It manages assets worth ₹6,830 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE Healthcare TRI. The current expense ratio is 1.86%.